Zoran Zdraveski, Chief Legal Officer at TScan Therapeutics, Inc. (TCRX), bought 4,716 shares at $7.48 ($35K) on 2021-09-23, disclosed to the SEC on 2021-09-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |